{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:00:51Z","timestamp":1791615651182,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.10.079","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T02:34:32Z","timestamp":1321238072000},"page":"398-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development of orf virus as a bifunctional recombinant vaccine: Surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins"],"prefix":"10.1016","volume":"30","author":[{"given":"Joanne L.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.10.079_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"Ulrich","year":"1998","journal-title":"Adv Virus Res"},{"issue":"27","key":"10.1016\/j.vaccine.2011.10.079_bib0010","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/S0264-410X(00)00112-2","article-title":"Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env","volume":"18","author":"Collado","year":"2000","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2011.10.079_bib0015","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/aid.1997.13.1497","article-title":"Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions","volume":"13","author":"Katz","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.vaccine.2011.10.079_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/088282402760312340","article-title":"Ultraviolet-irradiated vaccinia virus recombinants, exposing HIV-envelope on their outer membrane, induce antibodies against this antigen in rabbits","volume":"15","author":"Loewinger","year":"2002","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","article-title":"Danger signals: SOS to the immune system","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr Opin Immunol"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2011.10.079_bib0030","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1016\/j.vaccine.2006.05.078","article-title":"Prime-boost immunisation using DNA vaccine and recombinant orf virus protects pigs against Pseudorabies virus (Herpes suid 1)","volume":"24","author":"Dory","year":"2006","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2011.10.079_bib0035","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1128\/JVI.77.17.9312-9323.2003","article-title":"Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpes virus challenge infection in mice","volume":"77","author":"Fischer","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.10.079_bib0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00705-002-0948-6","article-title":"Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site","volume":"148","author":"Marsland","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0045","series-title":"Recombinant poxviruses","first-page":"285","article-title":"Parapoxviruses: their biology and potential as recombinant vaccines","author":"Robinson","year":"1992"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2011.10.079_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-1656(99)00141-8","article-title":"Parapoxviruses: potential alternative vectors for directing the immune response in permissive and non-permissive hosts","volume":"73","author":"Rziha","year":"1999","journal-title":"J Biotechnol"},{"issue":"31","key":"10.1016\/j.vaccine.2011.10.079_bib0055","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1016\/j.vaccine.2007.05.035","article-title":"Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2)","volume":"25","author":"Voigt","year":"2007","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.10.079_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(02)00117-X","article-title":"Immunity and counter-immunity during infection with the parapoxvirus orf virus","volume":"88","author":"Haig","year":"2002","journal-title":"Virus Res"},{"issue":"22","key":"10.1016\/j.vaccine.2011.10.079_bib0065","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.75.22.11034-11055.2001","article-title":"Structure and assembly of intracellular mature vaccinia virus: isolated-particle analysis","volume":"75","author":"Griffiths","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.10.079_bib0070","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1128\/JVI.76.4.1839-1855.2002","article-title":"Endoplasmic reticulum\u2013Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly","volume":"76","author":"Risco","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.10.079_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.121.3.521","article-title":"Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks","volume":"121","author":"Sodeik","year":"1993","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.10.079_bib0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/jvi.55.3.651-659.1985","article-title":"Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment","volume":"55","author":"Hiller","year":"1985","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/jvi.68.1.130-147.1994","article-title":"Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network","volume":"68","author":"Schmelz","year":"1994","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.10.079_bib0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virusres.2005.09.011","article-title":"Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation","volume":"116","author":"Mercer","year":"2006","journal-title":"Virus Res"},{"issue":"Pt. 3","key":"10.1016\/j.vaccine.2011.10.079_bib0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1099\/vir.0.005488-0","article-title":"Investigation of orf virus structure and morphogenesis using recombinants expressing FLAG-tagged envelope structural proteins: evidence for wrapped virus particles and egress from infected cells","volume":"90","author":"Tan","year":"2009","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2011.10.079_bib0100","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1128\/JVI.78.15.8085-8093.2004","article-title":"Appearance of the bona fide spiral tubule of ORF virus is dependent on an intact 10-kilodalton viral protein","volume":"78","author":"Spehner","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.10.079_bib0105","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s007050050461","article-title":"The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39kDa immunodominant protein","volume":"143","author":"Housawi","year":"1998","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2004.04.018","article-title":"Heparin binding activity of orf virus F1L protein","volume":"105","author":"Scagliarini","year":"2004","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3201\/eid1202.050499","article-title":"Global socioeconomic impact of cystic echinococcosis","volume":"12","author":"Budke","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2011.10.079_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/pro.5560020714","article-title":"Fibronectin type III modules in the receptor phosphatase CD45 and tapeworm antigens","volume":"2","author":"Bork","year":"1993","journal-title":"Protein Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2011.10.079_bib0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-3024.1996.d01-114.x","article-title":"Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules","volume":"18","author":"Heath","year":"1996","journal-title":"Parasite Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.10.079_bib0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0020-7519(94)90156-2","article-title":"Echinococcus granulosus: the mechanism of oncosphere lysis by sheep complement and antibody","volume":"24","author":"Heath","year":"1994","journal-title":"Int J Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.10.079_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3024.1996.tb01029.x","article-title":"Vaccination against hydatidosis using a defined recombinant antigen","volume":"18","author":"Lightowlers","year":"1996","journal-title":"Parasite Immunol"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2011.10.079_bib0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0264-410X(00)00192-4","article-title":"Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes","volume":"19","author":"Woollard","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01315174","article-title":"The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf virus in sheep","volume":"71","author":"Robinson","year":"1982","journal-title":"Arch Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.10.079_bib0150","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/jvi.71.6.4857-4861.1997","article-title":"A homolog of interleukin-10 is encoded by the poxvirus orf virus","volume":"71","author":"Fleming","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-0934(97)00045-1","article-title":"A synthetic vaccinia virus promoter with enhanced early and late activity","volume":"66","author":"Hammond","year":"1997","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/jvi.60.2.436-449.1986","article-title":"Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment","volume":"60","author":"Rosel","year":"1986","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(87)90307-2","article-title":"The structure and cloning of orf virus DNA","volume":"157","author":"Mercer","year":"1987","journal-title":"Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.10.079_bib0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molimm.2003.08.006","article-title":"Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression","volume":"40","author":"Trinh","year":"2004","journal-title":"Mol Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2011.10.079_bib0175","doi-asserted-by":"crossref","first-page":"10699","DOI":"10.1128\/JVI.74.22.10699-10706.2000","article-title":"Viral vascular endothelial growth factor plays a critical role in orf virus infection","volume":"74","author":"Savory","year":"2000","journal-title":"J Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2011.10.079_bib0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF01314426","article-title":"Orf virus replication in bovine testis cells: kinetics of viral DNA, polypeptide, and infectious virus production and analysis of virion polypeptides","volume":"97","author":"Balassu","year":"1987","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0185","series-title":"Vaccinia virus and poxvirology methods and protocols","article-title":"Methods for analysis of poxvirus DNA replication","author":"Traktman","year":"2004"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jviromet.2009.04.031","article-title":"Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme-linked immunosorbent assay","volume":"161","author":"Bowden","year":"2009","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2011.10.079_bib0195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0022-5320(66)80077-1","article-title":"Controlled degradation of vaccinia virions in vitro: an electron microscopic study","volume":"14","author":"Easterbrook","year":"1966","journal-title":"J Ultrastruct Res"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nbt0197-29","article-title":"Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines","volume":"15","author":"Georgiou","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.10.079_bib0210","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/cr000261r","article-title":"Filamentous phage display in the new millennium","volume":"105","author":"Kehoe","year":"2005","journal-title":"Chem Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2011.10.079_bib0215","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.0409798102","article-title":"Using a baculovirus display library to identify MHC class I mimotopes","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt. 11","key":"10.1016\/j.vaccine.2011.10.079_bib0220","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1099\/13500872-141-11-2839","article-title":"Chimeric FimH adhesin of type 1 fimbriae: a bacterial surface display system for heterologous sequences","volume":"141","author":"Pallesen","year":"1995","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2011.10.079_bib0225","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0264-410X(89)90237-5","article-title":"Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization","volume":"7","author":"Leclerc","year":"1989","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.10.079_bib0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00253-003-1492-3","article-title":"Yeast cell-surface display \u2013 applications of molecular display","volume":"64","author":"Kondo","year":"2004","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.10.079_bib0235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/vr.138.8.184","article-title":"Tissue culture-propagated orf virus vaccine protects lambs from orf virus challenge","volume":"138","author":"Nettleton","year":"1996","journal-title":"Vet Rec"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2011.10.079_bib0240","first-page":"311","article-title":"Ovine diseases","volume":"29","author":"Haig","year":"1998","journal-title":"Orf Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2004.02.007","article-title":"Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion","volume":"322","author":"Kwak","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0250","first-page":"571","article-title":"Ecthyma contagieux du mouton: anticorps seriques neutralisants","volume":"3","author":"Poulain","year":"1972","journal-title":"Ann Rech Vet"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.079_bib0255","first-page":"343","article-title":"Transfer of antibodies against CPD virus through colostrum and milk","volume":"9","author":"Jan","year":"1978","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.exppara.2009.08.012","article-title":"Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs","volume":"123","author":"Fukumoto","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2011.10.079_bib0265","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.vaccine.2009.12.004","article-title":"Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs","volume":"28","author":"van Rooija","year":"2010","journal-title":"Vaccine"},{"issue":"Pt. 7","key":"10.1016\/j.vaccine.2011.10.079_bib0270","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1099\/vir.0.19138-0","article-title":"Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus","volume":"84","author":"Weber","year":"2003","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:54Z","timestamp":1759400454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11017294"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of orf virus as a bifunctional recombinant vaccine: Surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}